Envoy Medical Hits Enrollment Milestone in Pivotal Acclaim Cochlear Implant Trial
I'm PortAI, I can summarize articles.
Envoy Medical Inc. has reached the midway point in enrollment for its pivotal Acclaim® cochlear implant trial, aiming for completion by early 2026. The implant uses a piezoelectric sensor to capture sound naturally. Results are pending post-enrollment. This AI-generated brief is informational, not financial advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments